Antiischemic Effects of SB203580 Are Mediated Through the Inhibition of p38&agr; Mitogen-Activated Protein KinaseEvidence From Ectopic Expression of an Inhibition-Resistant Kinase
作者:
Jody Martin,
Metin Avkiran,
Roy Quinlan,
Philip Cohen,
Michael Marber,
期刊:
Circulation Research: Journal of the American Heart Association
(OVID Available online 2001)
卷期:
Volume 89,
issue 9
页码: 750-752
ISSN:0009-7330
年代: 2001
出版商: OVID
关键词: SB203580;p38 mitogen-activated protein kinase;preconditioning;isolated cells;signaling
数据来源: OVID
摘要:
The aim of the present study was to determine whether the attenuation of myocardial ischemic injury by SB203580 is due to the inhibition of p38 mitogen-activated protein kinase (MAPK) or to other documented nonspecific effects of the drug. We made adenoviral vectors encoding the &agr; isoform of p38 MAPK with or without site-directed mutations to prevent SB203580 binding and inhibition. In embryonal rat heart–derived cells and adult rat cardiocytes expressing wild-type p38&agr; MAPK, injury was reduced significantly by SB203580 present during simulated ischemia. In contrast, SB203580 did not protect cells expressing the SB203580-resistant form of p38&agr; MAPK. These observations suggest that SB203580-mediated protection depends on the inhibition of p38&agr; MAPK.
点击下载:
PDF
(963KB)
返 回